Key Takeaways Tempus AI is developing TIME to speed oncology trial matching and enrollment for providers and patients. Tempus Next analyzes EMR data, notes, molecular data and imaging to flag care gaps and guide treatment. Tempus One uses proprietary LLM agents to support clinical decisions and help advance drug research. Beyond diagnostics and data licensing, Tempus AI (TEM) is also focused on monetizing clinical applications and healthcare software designed for healthcare providers. The company is develop ...